Selepam: Full Drug Profile
Selepam - General Information
Selepam is a drug which is a benzodiazepine derivative. It induces impairment of motor function and has hypnotic properties. Selepam is used to treat insomnia.
Pharmacology of Selepam
Selepam is a benzodiazepine derivative. The main pharmacological action of quazepam is the enhancement of the neurotransmitter, GABA at the GABAA receptor.
Additional information about Selepam
Selepam Indication: Used to treat insomnia. Mechanism Of Action: Benzodiazepines bind nonspecifically to benzodiazepine receptors, which affects muscle relaxation, anticonvulsant activity, motor coordination, and memory. As benzodiazepine receptors are thought to be coupled to gamma-aminobutyric acid-A (GABAA) receptors, this enhances the effects of GABA by increasing GABA affinity for the GABA receptor. Binding of the inhibitory neurotransmitter GABA to the site opens the chloride channel, resulting in a hyperpolarized cell membrane that prevents further excitation of the cell. Drug Interactions: Not Available Food Interactions: Not Available Generic Name: Quazepam Synonyms: Quazepamum [inn-latin] Drug Category: Anti-anxiety Agents; Benzodiazepines; GABA Modulators Drug Type: Small Molecule; Illicit; Approved Other Brand Names containing Quazepam: Cetrane; Doral; Dormalin; Oniria; Prosedar; Quazium; Selepam; Absorption: Bioavailability is 29-35% following oral administration. Toxicity (Overdose): Not Available Protein Binding: Not Available Biotransformation: Hepatic. Half Life: 39 hours Dosage Forms of Selepam: Tablet Oral Chemical IUPAC Name: 7-chloro-5-(2-fluorophenyl)-1-(2,2,2-trifluoroethyl)-3H-1,4-benzodiazepine-2-thione Chemical Formula: C17H11ClF4N2S Quazepam on Wikipedia: https://en.wikipedia.org/wiki/Quazepam Organisms Affected: Humans and other mammals